2022 December 27
1.
FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review). Meng X, Peng L, Wei X, Li S.
Mol Med Rep. 2023 Feb;27(2):34. doi: 10.3892/mmr.2022.12921. Epub 2022 Dec 23.
PMID: 36562359 Review.
2.
Circular RNA circFoxo3 Promotes Granulosa Cell Apoptosis Under Oxidative Stress Through Regulation of FOXO3 Protein. Chen L, Zhu L, Fang J, Zhang N, Li D, Sheng X, Zhou J, Wang S, Wang J.
DNA Cell Biol. 2022 Dec;41(12):1026-1037. doi: 10.1089/dna.2022.0449. Epub 2022 Nov 17.
PMID: 36394459
3.
Circ_FOXO3 regulates KLF6 through sponge adsorption of miR-122-5p to repress H2O2-induced HBVSMC proliferation, thus promoting IA development in vitro model. Yue PD, Lu YN, Zhang L, Ma ZF.
Acta Biochim Pol. 2022 Oct 22;69(4):767-772. doi: 10.18388/abp.2020_6021.
PMID: 36272155
4.
FoxO3 and oxidative stress: a multifaceted role in cellular adaptation. Bernardo VS, Torres FF, da Silva DGH.
J Mol Med (Berl). 2023 Jan 4. doi: 10.1007/s00109-022-02281-5. Online ahead of print.
PMID: 36598531 Review.